经支气管肺活检诊断淋巴管肌瘤病的疗效与安全性:24例连续病例报告
该研究回顾性分析了1991年至2015年间24例接受经支气管肺活检(TBLB)的淋巴管肌瘤病(LAM)女性患者,评估其诊断效能与安全性。结果显示17例(70.8%)经病理确诊,且无气胸或不可控出血等严重不良事件,提示TBLB是LAM病理诊断的安全有效方法。
要点
- TBLB对LAM的病理诊断阳性率为70.8%(17/24)。
- TBLB未发生气胸或不可控出血等严重不良事件。
- TBLB阳性者一氧化碳弥散量占预计值百分比显著低于阴性者(P=0.046)。
核心结论
- TBLB是LAM病理诊断的安全有效方法。
研究设计与样本
- 回顾性研究,1991年1月至2015年8月前瞻性注册的131例连续LAM患者中,24例接受了TBLB。
主要发现
- 24例均为女性,中位年龄42岁。
- HRCT显示双肺弥漫分布的多个圆形薄壁囊肿。
- 血清VEGF-D中位水平为2109 pg/mL。
- 两名病理专家在17例(70.8%)中识别出LAM特征性病理表现。
- 17例TBLB阳性LAM患者的一氧化碳弥散量占预计值百分比显著低于7例TBLB阴性LAM患者(P=0.046)。
临床怎么用
- 对于不符合临床诊断标准的LAM患者,可考虑TBLB进行组织确诊。
局限性
- 回顾性研究,样本量小(24例接受TBLB),来自单中心注册队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Lymphangioleiomyomatosis (LAM) is a diffuse cystic lung disease that occurs in women of childbearing age. LAM can be diagnosed on a clinical basis in patients with typical high-resolution computed tomography (HRCT) patterns and at least one other corroborating disease feature, such as chylothorax, angiomyolipoma, tuberous sclerosis complex or elevated serum vascular endothelial growth factor (VEGF)-D. However, patients who do not meet these criteria require tissue confirmation for a definitive diagnosis, and the utility of methods that are less invasive than surgical lung biopsy, such as transbronchial lung biopsy (TBLB), are not well studied. We retrospectively studied the efficacy and safety of TBLB for the diagnosis of LAM. METHODS: From January 1991 to August 2015, 131 consecutive LAM patients were prospectively registered in our study, and a TBLB was conducted for 24 patients. We retrospectively studied the yield and safety of TBLB in this cohort. RESULTS: All 24 patients were women; the median age was 42 years. HRCT showed multiple round thin-walled cysts diffusely scattered throughout the lungs. The median level of serum VEGF-D was 2109 pg/mL. Characteristic pathological findings for LAM were identified in 17 patients (70.8%) by two expert pathologists. The %predicted value for diffusing capacity of carbon monoxide was significantly lower in the 17 TBLB-positive LAM patients compared to the seven TBLB-negative LAM patients (P = 0.046). There were no serious adverse events such as pneumothorax or uncontrollable bleeding due to TBLB. CONCLUSION: TBLB is a safe and effective method for the pathological diagnosis of LAM.
引用
- Koba T, Arai T, Kitaichi M, et al. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients. Respirology. 2017. PMID: 28960664. doi:10.1111/resp.13190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。